Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

9(81.8%)

N/A

2(18.2%)

11Total

Phase 2(9)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT05297019Phase 2Unknown

A Dosing Study of Hyperbaric Oxygen Therapy (HBOT) on Epigenetic Aging

Role: lead

NCT05234203Not ApplicableCompleted

The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age

Role: collaborator

NCT05535608Phase 2Unknown

Targeting the Nine Hallmarks of Aging on DNA Methylation

Role: lead

NCT05297097Phase 2Unknown

The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers

Role: lead

NCT05294835Phase 2Unknown

Ketamine and Epigenetic Aging

Role: lead

NCT05296993Phase 2Unknown

Safety & Efficacy of Extended Longevity Protocol

Role: lead

NCT05310123Phase 2Unknown

AC-11 Supplement and Biological Aging

Role: lead

NCT05001646Phase 2Unknown

Electromagnetic Field Protection Device Use Impact in Healthy Volunteers

Role: lead

NCT04988542Not ApplicableUnknown

Clinical Efficacy of a Supplement on Sleep Quality

Role: lead

NCT04946383Phase 2Unknown

Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging

Role: lead

NCT04962464Phase 2Unknown

The Impact of a Fast Diet and Calorie Mimetic Supplements on Epigenetic Aging

Role: lead

NCT04939155Unknown

Methylation Effects of COV-19 Infection and Vaccinations

Role: lead

All 12 trials loaded